The investigation of yrecombinant human IGF-I (ınsulin like growth factor-I) ınjection on rats liver malondealdehyde and reduced glutathione levels
Bu çalışmada deney hayvam olarak, ağırlıkları 95±5 g arasında değişen 30 adet dişi rat (Wistar albino), kontrol ve deney olarak 15'er hayvanlık iki gruba ayrıldı ve ayrı kafeslere alındı. Deney grubundaki ratlara 7 gün boyunca her 24 saatte bir 100 ng/kg/gün dozunda rekombinat human Insulin-Like Growth Factor-I (rh IGF-I), kontrol grubuna ise sadece 0.01 M NaHCO3 subkutan olarak enjekte edildi. Yedi günlük enjeksiyonu takip eden 8, 15 ve 22. günlerde ratlar tartılarak karaciğer dokuları alındı. Enjeksiyonun 7. gününde kontrol grubundan alman karaciğer örneklerinde malondialdehit (MDA) ve redükte glutatyon (GSH) düzeylerinde istatistiksel olarak önemli bir değişim görülmedi. Onbeşinci günde MDA düzeylerinde istatistiksel olarak önemli bir artış görülürken, GSH düzeyinde aynı oranda bir azalış görüldü. Yirmiikinci günde hem MDA hem de GSH düzeylerinde önemli bir azalma kaydedildi (p
Recombinant human IGF-I (Insülin-like growth factor-I)Enjeksiyonu yapılan ratlarda karaciğer malondialdehit ve redükte glutatyon düzeylerinin araştırılması
The effect of insulin-like growth factor-I (IGF-I) administration on lipid peroxidation and reducted glutathione in liver of rats was studied. Total of 30 female rats (Wistar albino), weighing 95±5g, were divided into two groups and kept in two separete cages. The second group (n=15) was rh IGF-I (100 ng/kg/day) in 0.01 M NaHCO3) was subcutananeusly injected tor at for a 7 days period. Also, first group (control group (n=15)) was subcutananeusly received 0.01 M NaCHO3 in same manner with rh IGF-I treated group. At the end of injection period, at 8th, 15th and 22nd days, rats have been weighed and liver tissues were removed. At the 7th injection day, removed liver tissues from control group has been examined and has not been seen any significant changes statistically. At the 15th injection day, has seen that MDA levels are increased (P<0.01) and GSH levels are decreased (P<0.01) statistically. On the other hand at the 22nd day has been recorded that both MDA and GSH levels are decreased. These results showed that IGF-I has been important metabolic effect on the MDA and GSH.
___
- Knight JA: Free radicals: Their history and current status in aging and disease. Ann Clin Lab Sci, 28, 331-46, 1998.
- Toyokuni S: Reactive oxygen species-induced molecular damage and its application in pathology.. Pathollnt, 49,91-102,1999.
- Kramer JH, Mak T, Weblicki WB: Differential sensitivity of canine cardiac sarcolemmal and microsomal enzymes to inhibition by free radical induced lipid peroxidation. Circ Res, 55, 120-124, 1985.
- Rajguru SU, Yeargans GS, Seidler NW: Exercise causes oxidative damage tor at skeletal muscle microsomes while increasing cellular subhydryls. Life Sci, 54, 149-157, 1993.
- Nair V, Turner GA, Offerman R: Novel adducts from the modification of nucleic acid bases by malondialdehyde. / Am ChemSoc, 106,3370-3371, 1984.
- Bacon BR, Britton RS: Hepatic injury in 1chronic iron overload. Role lipid peroxidation. Chem Biol Interactions, 70, 183-226,1989.
- Bush AI: Metals and neuroscience. Curr Opin Chem Biol, 4, 184-191,2000.
- Lash LH, Putt DA: Renal cellular of exogeneous glutathione: Heterogenity at physiological and pharmacological concentrations. Biochem Pharm, 58, 897-907, 1999.
- Sara VR, Hall K: Insulin-like growth factor-I and their binding protein. PhysiolRew, 70,591-613, 1990.
- Muguerza B, Castilla-Cortazar I, Garcia M, Quiroga J, Santidrian S, Prieto J: Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. Biochem BiophysActa, 1536, 185-195,2001.
- Garcıa-Fernândez M, Castilla-Cortazar I, Diaz-Sanchez M, Navarro I, Puche JE, Castilla A, Casares AD, Clavijo E, Gonzâlez-Barön S: Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol, 5,7-13, 2005.
- Jones JI, Clemmons DR: Insulin growth factors and their binding proteins: biological actions. Endocr Rev, 16, 3-34, 1995.
- Caufriez A, Reding P, Urbain D, Goldstein J, Copinschi G: Insuline like growth factor-I: A good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. / Endocrinol Invest, 14,317-321, 1991.
- Picardi A, Costa De Oliveira A, Muguerza B, Tosar A, Quiroga J, Castilla-Cortâza I, Santidrian S, Prieto J: Low doses of insulin-lile growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol, 24, 267-279, 1997.
- Ohkawa H, Ohishi N, Yagi KL: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95,351-358,1979.
- Beutler E, Duron O, Kelly BM: Improved method for the determination of blood glutathione. / Lab Clin Med, 61, 882- 888, 1963.
- Lowry OH, Rosenbrough NJ, Far AL, Randal RJ: Protein measurement with the folin-phenol reagent. / Biol Chem, 193- 265, 1951.
- International Federation of Clinical Chemistry (IFFC): Eur J Clin Chem Biochem, 25, 337-342,1987.
- Sun Y: Free radicals, antioxidant enzymes and carcinogenesis. Free Rad Biol Med, 8, 583-589, 1990.
- Meister ME: Glutathione. Ann Rev Biochem, 52, 711-760, 1983.
- Güven A, Kaya N: Determination of reducted glutathione, glutathione S-transferase and selenium levels in goose liver cells with damage induced by carbon tetrachloride and ethanol. Tr J Vet Anim Sci, 29,1233-8, 2005.
- Güven A, Güven A, Gülmez M: The effect of kefir on the activities of GSH-Px, GST, CAT, GSH and LPO levels in carbon tetrachloride-induced mice tissues. J Vet Med B, 50, 412-416,2003.
- Castilla-Cortazar I, Aliaga-Montilla MA, Salvador J, Garcia M, Delgado G, Gonzalez-Baron S, Quiroga J, Prieto J: Insuline-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. Liver, 21, 405-409, 2001.
- Castilla-Cortazar I, Garcia M, Muguerza B, Perez R, Quiroga J, Santidrian S, Prieto J: Hepatoprotective effects of insulin-like growth factor-I in rats with carbon- tetrachloride-induced cirrhosis. Gastroenterology, 113, 1682- 1691, 1997.
- Daughaday WH: A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity. Perspect Biol Med, 32,194-211, 1989.